The Orlucent® System non-invasively determines the likelihood of malignancy potential for suspicious moles to provide greater certainty in clinical assessments of indeterminate pigmented lesions.
01
Fluorescent biotag is topically applied then wiped away
02
Handheld imager captures white light and fluorescent images
03
Software displays and analyzes images and provides a probability score indicating biological activity at a 7+ score suggestive of significant stromal tissue remodeling and a high likelihood of malignancy potential
Currently in Clinical Trials. Research Use Only in the US.
©2025 Orlucent, Inc.